Jae Mann Song, et al. meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. 49. Gerber GS, Thompson IM, Thisted R, Chodak GW. Disease-specific survival following routine prostate cancer screening by digital rectal examination. JAMA 1993;269:61-4. 50. Rifkin MD, Zerhouni EA, Gatsonis CA, Quint LE, Paushter DM, Epstein JI, et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: Results of a multi-institutional cooperative trial. N Eng J Med 1990;323:621-6. 51. American College of Preventive Medicine (ACPM). Screening for prostate cancer in American men. Am J Prev Med 1998;15:81-4. 52. American Urological Association (AUA). Prostatic-spe- cific antigen (PSA) best practice policy. Oncology (Huntingt) 2000;14:267-72, 277-8, 280 53. Singapore Ministry of Health (MOH). Prostate Cancer. Singapore: Ministry of Health (Singapore); 2000:49. (Ministry of Health Singapore clinical practice guide- lines; no. 3/100). 54. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, et al. ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Com- mittee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75. 55. U.S. Preventive Services Task Force (USPSTF). Screening for prostate cancer: recommendations and rationale. Ann Intern Med 2002;137:915-6. 56. National Guideline Clearinghouse (NGC). Guideline synthesis: Screening for prostate cancer. http://www. g u id e lin e . g ov / C om p ar e / co m pa r i s on . as p x? f ile = proscreen6.inc. 1998 (updated 2004). Yonsei Med J Vol. 46, No. 3, 2005